{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:16:28Z","timestamp":1792131388761,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vph.2022.107110","type":"journal-article","created":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T17:54:52Z","timestamp":1662918892000},"page":"107110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["\u0392-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro"],"prefix":"10.1016","volume":"146","author":[{"given":"Bruno","family":"Lorusso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cerasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Frati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gallia","family":"Graiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Nogara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Roti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cerretani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gherli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariafrancesca","family":"Caputi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Gnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Pilato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Quaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Lagrasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2022.107110_bb0005","doi-asserted-by":"crossref","first-page":"165S","DOI":"10.1016\/j.amjhyper.2005.09.010","article-title":"The role of \u03b2-blockers as a cornerstone of cardiovascular therapy","volume":"18","author":"Hollenberg","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2022.107110_bb0010","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1096\/fj.11-192435","article-title":"Predicting in vivo cardiovascular properties of \u03b2-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses","volume":"25","author":"Baker","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2022.107110_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tips.2011.02.010","article-title":"Evolution of \u03b2-blockers\u2014from anti-anginal drugs to ligand-directed signaling","volume":"32","author":"Baker","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vph.2022.107110_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/OTT.S38403","article-title":"\u03b2-Blockers: a novel class of antitumor agents","volume":"5","author":"Ji","year":"2012","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.vph.2022.107110_bb0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1476-5381.2011.01791.x","article-title":"Involvement of \u03b12- and 2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation","volume":"166","author":"Pi\u00f1ero","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2022.107110_bb0030","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer","volume":"18","author":"Cole","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.vph.2022.107110_bb0035","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.vph.2022.107110_bb0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1525-1470.2010.01221.x","article-title":"Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI)","volume":"27","author":"Abbott","year":"2010","journal-title":"Pediatr. Dermatol."},{"issue":"2","key":"10.1016\/j.vph.2022.107110_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-1470.2010.01224.x","article-title":"Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report","volume":"28","author":"Breur","year":"2011","journal-title":"Pediatr. Dermatol."},{"issue":"7","key":"10.1016\/j.vph.2022.107110_bb0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archdermatol.2010.158","article-title":"Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma","volume":"146","author":"Holland","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"6","key":"10.1016\/j.vph.2022.107110_bb0055","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1542\/peds.2010-0077","article-title":"Hyperkalemia complicating propranolol treatment of an infantile hemangioma","volume":"126","author":"Pavlakovic","year":"2010","journal-title":"Pediatrics."},{"issue":"2","key":"10.1016\/j.vph.2022.107110_bb0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","article-title":"Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants","volume":"65","author":"De Graaf","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.vph.2022.107110_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"Leaute-Labreze","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2022.107110_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc1503811","article-title":"Oral propranolol for Infantile Hemangioma","volume":"373","author":"Tozzi","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2022.107110_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","article-title":"Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas","volume":"172","author":"Langley","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.vph.2022.107110_bb0080","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bjps.2013.07.035","article-title":"Treatment of infantile hemangiomas with atenolol: comparison with historical propranolol group","volume":"66","author":"De Graaf","year":"2013","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"6","key":"10.1016\/j.vph.2022.107110_bb0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2014.01.905","article-title":"Atenolol versus propranolol for treatment of infantile hemangioma: a randomized controlled study","volume":"70","author":"\u00c1barz\u00faa-Araya","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.vph.2022.107110_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0034-1376259","article-title":"Beta-blockers as therapy for infantile hemangioma","volume":"28","author":"Nguyen","year":"2014","journal-title":"Semin. Plast. Surg."},{"key":"10.1016\/j.vph.2022.107110_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.08.020","article-title":"Infantile hemangioma. Part 2: Management","author":"Sebaratnam","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006460","article-title":"Infantile hemangioma-mechanism(s) of drug action on a vascular tumor","volume":"1","author":"Greenberger","year":"2011","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"2","key":"10.1016\/j.vph.2022.107110_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile hemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.vph.2022.107110_bb0110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3892\/etm.2012.654","article-title":"Propranolol treatment of infantile hemangioma endothelial cells: a molecular analysis","volume":"4","author":"Stiles","year":"2012","journal-title":"Exp Ther Med."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjd.13388","article-title":"The use of propranolol in the treatment of infantile hemangiomas: an update on potential mechanisms of action","volume":"172","author":"Ji","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI73943","article-title":"Autophagy in cardiovascular biology","volume":"125","author":"Lavandero","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2022.107110_bb0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/1440-1681.12649","article-title":"Autophagy in vascular endothelial cells","volume":"43","author":"Jiang","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.vph.2022.107110_bb0130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCRESAHA.116.303805","article-title":"The role of autophagy in vascular biology","volume":"116","author":"Nussenzweig","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.vph.2022.107110_bb0135","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/CIRCRESAHA.116.303804","article-title":"Autophagy in vascular disease","volume":"116","author":"De Meyer","year":"2015","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.vph.2022.107110_bb0140","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/bph.13052","article-title":"Autophagy: an emerging therapeutic target in vascular disease","volume":"172","author":"Vindis","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"7264","key":"10.1016\/j.vph.2022.107110_bb0145","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature08455","article-title":"Discovery of Atg5\/Atg7-independent alternative macroautophagy","volume":"461","author":"Nishida","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.vph.2022.107110_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/189794","article-title":"Alternative macroautophagic pathways","author":"Juenemann","year":"2012","journal-title":"Int J Cell Biol."},{"key":"10.1016\/j.vph.2022.107110_bb0155","article-title":"Regulation of autophagy by polyphenolic compounds as potential therapeutic strategy for cancer","volume":"6","author":"Hasima","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.vph.2022.107110_bb0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd3802","article-title":"Autophagy modulation as a potential therapeutic target for diverse diseases","volume":"11","author":"Rubinsztein","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2022.107110_bb0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nri3532","article-title":"Autophagy in infection, inflammation and immunity","volume":"13","author":"Deretic","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2022.107110_bb0170","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/bph.12477","article-title":"Autophagy and mitophagy in the myocardium: therapeutic potential and concerns","volume":"171","author":"Jimenez","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2022.107110_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/747864","article-title":"Isolation and characterization of human lung lymphatic endothelial cells","volume":"2015","author":"Lorusso","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.vph.2022.107110_bb0185","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3390\/ijms18091865","article-title":"Monitoring and measuring autophagy","volume":"18","author":"Yoshii","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.vph.2022.107110_bb0190","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy."},{"key":"10.1016\/j.vph.2022.107110_bb0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.devcel.2008.08.012","article-title":"The role of autophagy in mammalian development: cell makeover rather than cell death","volume":"15","author":"Cecconi","year":"2008","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI73946","article-title":"Essential role for autophagy in life span extension","volume":"125","author":"Madeo","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/imr.12422","article-title":"Autophagy proteins in antigen processing for presentation on MHC molecules","volume":"272","author":"M\u0169nz","year":"2016","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.vph.2022.107110_bb0210","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/nm.3288","article-title":"Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor","volume":"19","author":"Torisu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2022.107110_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gde.2014.04.003","article-title":"Autophagy and human disease: emerging themes","volume":"26","author":"Schneider","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"8","key":"10.1016\/j.vph.2022.107110_bb0220","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCRESAHA.111.300233","article-title":"Mitochondria and endothelial function","volume":"112","author":"Kluge","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2022.107110_bb0225","article-title":"Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases","author":"Hofmann","year":"2017","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2022.107110_bb0230","doi-asserted-by":"crossref","first-page":"9291","DOI":"10.1002\/jcb.28204","article-title":"Paeoniflorin attenuates oxidized low-density lipoprotein-induced apoptosis and adhesion molecule expression by autophagy enhancement in human umbilical vein endothelial cells","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrm3716","article-title":"The return of the nucleus: transcriptional and epigenetic control of autophagy","volume":"15","author":"F\u00fcllgrabe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2022.107110_bb0240","doi-asserted-by":"crossref","first-page":"398483","DOI":"10.1155\/2015\/398483","article-title":"Cellular and molecular connections between autophagy and inflammation","author":"Lapaquette","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.vph.2022.107110_bb0245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cvr\/cvr358","article-title":"Autophagy as a therapeutic target for ischaemia \/reperfusion injury? Concepts, controversies, and challenges","volume":"94","author":"Przyklenk","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.vph.2022.107110_bb0250","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4161\/auto.25969","article-title":"Cardiovascular autophagy","volume":"9","author":"Lavandero","year":"2013","journal-title":"Autophagy."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15548627.2017.1395114","article-title":"Endothelial autophagic flux hampers atherosclerotic lesion development","volume":"14","author":"Kheloufi","year":"2018","journal-title":"Autophagy."},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI73938","article-title":"Development of autophagy inducers in clinical medicine","volume":"125","author":"Levine","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.vph.2022.107110_bb0265","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/genes13081338","article-title":"BAG3 alleviates atherosclerosis by inhibiting endothelial-to-mesenchymal transition via autophagy activation","volume":"13","author":"Diao","year":"2022","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.vph.2022.107110_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI78652","article-title":"Autophagy: a druggable process that is deregulated in aging and human disease","volume":"125","author":"Kroemer","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.vph.2022.107110_bb0275","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.bbagen.2016.06.012","article-title":"Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer","volume":"1860","author":"Saleh","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.vph.2022.107110_bb0280","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd.2017.22","article-title":"Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles","volume":"16","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.vph.2022.107110_bb0285","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/15548627.2017.1287653","article-title":"Pharmacological modulators of autophagy active a parallel noncanonical pathway driving unconventional LC3 lipidation","volume":"13","author":"Jacquin","year":"2017","journal-title":"Autophagy."},{"issue":"18","key":"10.1016\/j.vph.2022.107110_bb0290","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1074\/jbc.RA120.012593","article-title":"Catabolic degradation of endothelial VEGFA via autophagy","volume":"295","author":"Neill","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.vph.2022.107110_bb0295","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4161\/auto.25881","article-title":"Decorin has an appetite for endothelial cell autophagy","volume":"9","author":"Neill","year":"2013","journal-title":"Autophagy."},{"issue":"3","key":"10.1016\/j.vph.2022.107110_bb0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/08880018.2021.1961956","article-title":"Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma","volume":"39","author":"Makkeyah","year":"2022","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"7436","key":"10.1016\/j.vph.2022.107110_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11866","article-title":"Identification of a candidate therapeutic autophagy-inducing peptide","volume":"494","author":"Shoji-Kawata","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vph.2022.107110_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106949","article-title":"Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: a potential rescue strategy","volume":"142","author":"Madonna","year":"2022","journal-title":"Vasc. Pharmacol."},{"issue":"41","key":"10.1016\/j.vph.2022.107110_bb0315","doi-asserted-by":"crossref","first-page":"E8675","DOI":"10.1073\/pnas.1702223114","article-title":"Autophagy is required for endothelial cells alignment and atherioprotection under physiological blood flow","volume":"114","author":"Vion","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2022.107110_bb0320","article-title":"Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury","author":"Ruart","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.vph.2022.107110_bb0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2019.10.028","article-title":"A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis","volume":"72","author":"Hammoutene","year":"2020","journal-title":"J. Hepatol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:22:17Z","timestamp":1761528137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189122001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":65,"alternative-id":["S1537189122001598"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2022.107110","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0392-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2022.107110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107110"}}